Praxis Precision Medicines (PRAX) Net Equity Issued and Repurchased (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Net Equity Issued and Repurchased of $621.2 million for Q1 2026, up 531.75% quarter-over-quarter from $98.3 million in Q4 2024.
Praxis Precision Medicines (PRAX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at $621.2 million for Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $621.2 million; the TTM figure through Mar 2026 stood at $621.2 million (up 1379.6% YoY), while the FY2024 annual figure was $113.1 million, up 78.28% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $621.2 million, up from $98.3 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $621.2 million in Q1 2026, with the low at -$146.9 million in Q2 2024.
- The 4-year median for Net Equity Issued and Repurchased is $18.1 million (2023), against an average of $88.6 million.
- The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased jumped 1222.81% in 2023, then tumbled 2535.08% in 2024.
- Praxis Precision Medicines' Net Equity Issued and Repurchased stood at -$1.4 million in 2022, then surged by 2973.61% to $39.3 million in 2023, then surged by 150.15% to $98.3 million in 2024, then surged by 531.75% to $621.2 million in 2026.
- Business Quant data shows PRAX's Net Equity Issued and Repurchased at $621.2 million in Q1 2026, $98.3 million in Q4 2024, and -$146.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 621.24 Mn |
| Mar 31, 2026 | 621.24 Mn |
| Dec 31, 2024 | 98.34 Mn |
| Dec 31, 2024 | 98.34 Mn |
| Jun 30, 2024 | -146.88 Mn |
| Jun 30, 2024 | -146.88 Mn |
| Mar 31, 2024 | 161.65 Mn |
| Mar 31, 2024 | 161.65 Mn |
| Dec 31, 2023 | 39.31 Mn |
| Dec 31, 2023 | 39.31 Mn |
| Jun 30, 2023 | 6.03 Mn |
| Jun 30, 2023 | 6.03 Mn |
| Mar 31, 2023 | 18.10 Mn |
| Mar 31, 2023 | 18.10 Mn |
| Sep 30, 2022 | -1.37 Mn |
| Sep 30, 2022 | -1.37 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | -67,000.00 |
| Dec 31, 2021 | -67,000.00 |